HOME
>
Video Archive
You’re not logged in!
Much of the content on this page is member exclusive. Join or login to gain access.
Oncoleader | Videos | The Hidden Advantage of In Vivo CAR Technology https://vimeo.com/1044136054?share=copy#t=0 Video Description Video Host Jeff Martin, PhD Founder Dr. Jeff Martin is a cancer biologist with a PhD in Cancer Genetics and over a decade of experience in immuno-oncology. As the Founder of Oncoleader, Jeff currently advises
Oncoleader | Videos | Don’t Underestimate This NK Cell Engager https://vimeo.com/1030200448?share=copy#t=0 Video Description Video Host Jeff Martin, PhD Founder Dr. Jeff Martin is a cancer biologist with a PhD in Cancer Genetics and over a decade of experience in immuno-oncology. As the Founder of Oncoleader, Jeff currently advises biotech professionals,
Oncoleader | Videos | Don’t Underestimate This NK Cell Engager https://vimeo.com/1031688720?share=copy#t=0 Video Description Video Host Jeff Martin, PhD Founder Dr. Jeff Martin is a cancer biologist with a PhD in Cancer Genetics and over a decade of experience in immuno-oncology. As the Founder of Oncoleader, Jeff currently advises biotech professionals, providing
Video description T cell exhaustion can severely hinder anti-cancer immune responses and several therapeutic modalities – including the most successful drug in medicine Merck’s KEYTRUDA – are designed to combat it. A paper published in Nature Immunology on November 8th our of the University of Pittsburgh describes how exhausted T
Video Description Welcome to Emerging Biotech: Today’s Insights Into Tomorrow’s Cancer Therapies. I’m Jeff, Founder here at Oncoleader. In this first episode, I’m examining Avenzo Therapeutics – a company that is absolutely poised to disrupt the industry. Avenzo has raised over 550 million dollars in three funding rounds over the
Description Last week, Autolus announced that they had received FDA approval for their autologous CAR-T cell therapy obe-cel (AUCATZYL) for use in adult r/r B-ALL. This is amazing news for the patients and the company – congrats to both! In this video, I explain the data that led to the
